Related Experiment Video

Updated: May 6, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

22.2K

High nasal burden of methicillin-resistant Staphylococcus aureus increases risk of invasive disease

Rupak Datta1, Atia Shah, Susan S Huang

  • 1Health Policy Research Institute, University of California Irvine School of Medicine, Irvine, California, USA.

Journal of Clinical Microbiology
|October 25, 2013
PubMed

Insights

High nasal colonization of methicillin-resistant Staphylococcus aureus (MRSA) significantly increases invasive infection risk. This study found a clear trend between higher nasal bacterial burden and infection severity in patients.

Area of Science:

  • Infectious Diseases
  • Clinical Microbiology
  • Epidemiology

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen.
  • Nasal carriage is a reservoir for MRSA transmission and infection.
  • Quantifying nasal burden is crucial for risk stratification.

Purpose of the Study:

  • To investigate the association between nasal MRSA burden and the risk of invasive infection.
  • To determine if higher nasal bacterial load correlates with increased infection incidence.

Main Methods:

  • Retrospective cohort study.
  • Analysis of 1,140 patients with MRSA.
  • Categorization of nasal bacterial burden (low, 1+ to 2+, 3+ to 4+).

Main Results:

  • 31% had low nasal MRSA burden, 54% had 1+ to 2+, and 15% had 3+ to 4+.
  • A significant trend (P = 0.007) showed increased infection risk with higher nasal burden.
  • Multivariate analysis confirmed high nasal burden as a significant predictor of invasive infection.

Conclusions:

  • Nasal MRSA burden is a critical factor in predicting invasive infection risk.
  • Higher levels of nasal MRSA colonization are associated with a greater likelihood of invasive disease.
  • Clinical management strategies may benefit from considering nasal MRSA burden.

More Related Videos

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition07:42

Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition

Published on: September 3, 2016

14.6K
A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection09:15

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection

Published on: February 28, 2019

11.9K

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
115
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
251
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
197
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
150
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
1.0K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.1K